APOE-ε2 allele associated with higher pevalence of sporadic Parkinson disease

Neurology

Volumn 62, Issue 12, 2004, Pages 2198-2202

  Huang, Xuemei ^a   Chen, Peter C ^b   Poole, Charles ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 2; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ALLELE; CLINICAL TRIAL; GENETICS; GENOTYPE; REVIEW;

ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; GENE FREQUENCY; GENOTYPE; HUMANS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 2942711631     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000130159.28215.6A     Document Type: Article

References (39)

1. Mahley RW, Rall SC Jr. Apolipoprotein E. Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-537.
2. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994;344:889.
3. Marder K, Maestre G, Cote L, et al. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 1994;44:1330-1331.
4. Rubinsztein DC, Hanlon CS, Irving RM, et al. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 1994;8:519-525.
5. Ibarreta D, Gomez-Isla T, Portera-Sanchez A, Parrilla R, Ayuso MS. Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. J Neurol Sci 1995;134:146-149.
6. Poduslo SE, Riggs D, Rolan T, Schwankhaus J. Apolipoprotein E and B alleles in Parkinson's patients. Neurosci Lett 1995;194:145-147.
7. Helisalmi S, Linnaranta K, Lehtovirta M, et al. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett 1996;205:61-64.
8. Whitehead AS, Bertrandy S, Finnan F, et al. Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;61:347-351.
9. Bon MA, Jansen Steur EN, de Vos RA, Vermes I. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett 1999;266:149-151.
10. Kruger R, Vieira-Saecker AM, Kuhn W, et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/ apolipoprotein E genotype. Ann Neurol 1999;45:611-617.
11. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
12. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
13. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999;18:2693-2708.
14. 1-antichymotrypsin A-allele in German Parkinson disease patients. J Neural Transm 1999;106:729-736.
15. Oliveri RL, Nicoletti G, Cittadella R, et al. Apolipoprotein E polymorphisms and Parkinson's disease. Neurosci Lett 1999;277:83-86.
16. Morris CM, Massey HM, Benjamin R, et al. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. J Neural Transm Suppl 1996;205-218.
17. DeKroon RM, Mihovilovic M, Goodger ZV, et al. Apolipoprotein E genotype: specific inhibition of apoptosis. J Lipid Res 2003;44:1566-1573.
18. Tan EK, Khajavi M, Thornby JI, et al. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000;55:533-538.
19. Zareparsi S, Camicioli R, Sexton G, et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 2002;107:156-161.
20. Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Genomics 2002;79:458-461.
21. Han SH, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994;128:13-26.
22. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994;145:1472-1484.
23. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein-e genotypes in Parkinson disease with and without dementia. Ann Neurol 1995;37:242-245.
24. Martinoli MG, Trojanowski JQ, Schmidt ML, et al. Association of apolipoprotein epsilon-4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol 1995;90:239-243.
25. Egensperger R, Bancher C, Kosel S, et al. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions. Biochem Biophys Res Commun 1996;224:484-486.
26. Ballering LAP, Steffens-Nakken HM, Esselink RAJ, et al. Apolipoprotein E genotyping in patients with neurodegenerative diseases. Clin Biochem 1997;30:405-411.
27. Durr A, Medjbeur S, Didierjean O, et al. Apolipoprotein E genotype in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:394-395.
28. 1 -antichymotrypsin polymorphism. Brain Res 1997;759:153-155.
29. Harhangi BS, de Rijk MC, van Duijn CM, et al. APOE and the risk of PD with or without dementia in a population-based study. Neurology 2000;54:1272-1276.
30. Goetz CG, Burke PF, Leurgans S, et al. Genetic variation analysis in Parkinson disease patients with and without hallucinations-case-control study. Arch Neurol 2001;58:209-213.
31. Eerola J, Launes J, Hellstrom O, Tienari PJ. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland. Neurosci Lett 2002;330:296-298.
32. Tang GM, Xie HJ, Xu L, et al. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 2002;114:446-449.
33. Schulte T, Bohringer S, Schols L, et al. Modulation of disease risk according to a cathepsin D/apolipoprotein E genotype in Parkinson's disease. J Neural Transm 2003;110:749-755.
34. Hardy J, Crook R, Prihar G, et al. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett 1994;182:1-2.
35. St. Clair D. Apolipoprotein E gene in Parkinson's disease, Lewy body dementia and Alzheimer's disease. J Neural Transm Suppl 1997;51:161-165.
36. Arai H, Higuchi S, Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology 1997;43(suppl 1):2-10.
37. Mattila PM, Koskela T, Roytta M, et al. Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol (Berl) 1998;96:417-420.
38. Higuchi S, Matsushita S, Nakane J, et al. Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease. Neuroreport 2000;11:1167-1171.
39. Galasko D, Salmon DP, Craig UK, et al. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002;58:90-97.